Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. It focuses on drug development of untapped biological pathways implicated in cancer progression. The company was founded by David F. Hale and James B. Breitmeyer in 1997 and is headquartered in San Diego, CA.
Candlestick & Bollinger Bands
News Feed
- Oncternal Therapeutics Inc. advanced stock charts by MarketWatch. View ONCT historial stock data and compare to other stocks and exchanges. More
- Eastman Kodak (NYSE:KODK)+76%as DFC says no laws were broken.Greenland Technologies Holding (NASDAQ:GTEC) +60%on launching ‘electric industrial vehicle market’ divisionObalon Therapeutics (NASDAQ:OBLN) +52%.Oncternal Therapeutics (NASDAQ:ONCT) +27%onpresentationof interim Phase 1/2 data update for cirmtuzumab in combination with ibrutinib.Hennessy Capital Acquisition IV (NASDAQ:HCAC) +24%.Anworth Mortgage Asset (NYSE:ANH) +15%on being acquired by Ready Capital.Chimerix (NASDAQ:CMRX) +15%after FDA accepts NDA for smallpox countermeasure.Second Sight Medical Products (NASDAQ:EYES) +14%.Safe-T Group (NASDAQ:SFET) +15%.Matinas BioPharma Holdings (NYSEMKT:MTNB) +14%on evaluating oral formulations of Gileads antiviral remdesivir.Micro Focus International plc (NYSE:MFGP) +13%.Perion Network (NASDAQ:PERI) +13%on raising outlook.Uranium Energy (NYSEMKT:UEC) +12%as U.S. More
- Esperion Therapeutics, Inc. (ESPR) shares are sliding nearly 11 percent on Tuesday morning trade as the company reported wider net loss for the third quarter from the prior year. More
- Teledyne Technologies Incorporated (NYSE:TDY) will hold a conference call to discuss its third quarter 2020 results on Wednesday, October 21, 2020, at 8:00 a.m. Pacific. A press release with the third quarter financial results will be issued before the opening of the New York Stock Exchange on Wednesday, October 21, 2020. More
- Regulus Therapeutics is today’s best biotech stock as its shares more than doubled following the release of positive interim hepatitis C drug data. More
©Copyright 2020
5Charts.com